Form 4: Pacira BioSciences CMO Executes Tax-Related Share Sale
Statement of Changes in Beneficial Ownership
Chief Medical Officer Jonathan Slonin disposed of 4,728 shares of Pacira BioSciences to satisfy tax withholding obligations.
Summary
- Jonathan Slonin, Chief Medical Officer of Pacira BioSciences, Inc., reported the disposition of 4,728 shares of common stock.
- The transaction occurred on June 3, 2026, at a price of $22.32 per share.
- The shares were withheld by the issuer to cover tax withholding obligations related to the vesting of restricted stock units.
- Following this transaction, the reporting person maintains a beneficial ownership of 218,912.175 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine administrative tax transaction rather than a strategic or market-driven decision.
Positives
- The transaction was a mandatory tax withholding event rather than a discretionary open-market sale, indicating no change in the officer's long-term confidence in the company.
Negatives
- Reduction in the total number of shares held directly by the Chief Medical Officer.
Risks
- None identified; this is a routine administrative transaction.
Future Outlook
No forward-looking guidance or strategic outlook provided in this filing.
Industry Context
StockSavvy.ai notes that routine tax-related share withholdings are standard corporate practice for executives and do not typically signal shifts in corporate strategy or insider sentiment regarding company performance.
Comparison to Industry Standards
- The transaction follows standard SEC reporting requirements for equity compensation vesting.
- The use of 'sell-to-cover' or share withholding is a common practice among biotechnology firms to manage tax liabilities for executives.
Stakeholder Impact
- Minimal impact on shareholders as the transaction was a non-discretionary tax withholding event.
Next Steps
- No future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 06/03/2026 | Date of the transaction involving the withholding of shares for tax purposes. |
| 06/05/2026 | Date the Form 4 was signed and filed with the SEC. |
Keywords
Pacira BioSciences, PCRX, Insider Trading, Form 4, Chief Medical Officer, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.